FindTrial
Sign In

Identifying changes in tumour due to surgery.

Assessment of changes in hypoxia related biomarkers during surgery in resectable non-small cell lung cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/10/010260
Enrollment
10
Registered
2017-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with resectable non small cell lung cancer (NSCLC)who are Planned for surgery and have not received any prior treatment.

Interventions

Intervention1: Surgical Biopsy: Tumor biopsies performed preoperatively or at surgery before handling the tumour, intraoperatively (partial and complete ligation of the pulmonary vascu-lar supply) wil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with resectable non small cell lung cancer (NSCLC)who are planned for surgery and have not received any prior treatment

Exclusion criteria

Exclusion criteria: Histological diagnosis other than non small cell lung cancer (NSCLC)or NSCLC Patients who have received prior treatment

Design outcomes

Primary

MeasureTime frame
Identification of biological changes/ molecular changes happening in tumour tissue on account of surgery induced hypoxia to be reportedTimepoint: Identification of biological changes/ molecular changes happening in tumour tissue on account of surgery induced hypoxia to be reported—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactSabita Jiwnani

Tata Memorial hospital

sabitajiwnani@gmail.com02224176667

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026